Dodging Diabetes, Inc. – Trademark Portfolio
Entity Type: 99
Dodging Diabetes, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 4 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include DODGING DIABETES. The owner is based in Chevy Chase, MD.
3512 Leland Street
Chevy Chase, MD 20815
Showing of trademarks Trademarks
Trademark Classifications
Dodging Diabetes, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Dodging Diabetes, Inc. have?
Dodging Diabetes, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 abandoned, 1 cancelled.
What trademark classes does Dodging Diabetes, Inc. file in?
Dodging Diabetes, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Dodging Diabetes, Inc.'s most well-known trademarks?
Dodging Diabetes, Inc.'s registered trademark portfolio includes well-known marks such as DODGING DIABETES. These are among 1 currently registered trademark in the portfolio.
What is Dodging Diabetes, Inc.'s trademark registration success rate?
Dodging Diabetes, Inc. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.